Internal Medicine, Cardiovascular Disease · Forest Hills, NY
NPI
1467447235
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
10124 Queens Blvd, Suite A
Forest Hills, NY, 11375
Phone (718) 261-8881
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
16,461 services
Medicare patients, 2024
1,264
Average age 79
Drug cost, 2024
$3.7M
19,463 prescriptions
Company payments, 2025
$1,768
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mikhail Kapchits was code 99490 (chronic, principal, and transitional care management), 3,632 times for 542 patients. In total Mikhail Kapchits billed 16,461 services in 53 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 3,632 | 542 | $59.25 | $215K |
| 93000 Electrocardiogram | Office | 1,779 | 865 | $13.76 | $24K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,629 | 334 | $46.28 | $75K |
| 99214 Office E&M - Established | Office | 1,381 | 744 | $119.67 | $165K |
| 99454 E&M - Miscellaneous | Office | 1,227 | 174 | $47.67 | $58K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 814 | 210 | $6.70 | $5,455 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 662 | 333 | $104.73 | $69K |
| 99213 Office E&M - Established | Office | 612 | 420 | $83.74 | $51K |
| 93306 Echocardiography (TTE/TEE) | Office | 574 | 569 | $160.30 | $92K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 523 | 522 | $187.70 | $98K |
| 99457 E&M - Miscellaneous | Office | 426 | 127 | $47.63 | $20K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 406 | 135 | $60.45 | $25K |
| 99458 E&M - Miscellaneous | Office | 344 | 100 | $38.09 | $13K |
| 78452 Myocardial Perfusion Scan | Office | 334 | 334 | $431.22 | $144K |
| 93015 Electrocardiogram | Office | 332 | 331 | $61.03 | $20K |
By year: 2022 $1.7M for 23,053 services; 2023 $1.3M for 18,887 services; 2024 $1.3M for 16,461 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 325 | 249 | $8.65 | $2,811 |
| 83880 Clinical Chemistry | 200 | 168 | $38.47 | $7,694 |
Medicare prescription drug claims, 2024
In 2024, the drug Mikhail Kapchits prescribed most often to Medicare patients was Amlodipine Besylate, with 1,364 prescriptions and refills. In total Mikhail Kapchits wrote 19,463 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,364 | 1,743 | 286 | $2,814 |
| Eliquis Apixaban | 1,278 | 1,453 | 198 | $873K |
| Metoprolol Succinate Generic | 945 | 1,185 | 167 | $7,536 |
| Jardiance Empagliflozin | 741 | 831 | 133 | $477K |
| Spironolactone Generic | 711 | 809 | 144 | $1,848 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 676 | 870 | 165 | $11K |
| Nebivolol Hcl Generic | 615 | 736 | 127 | $20K |
| Carvedilol Generic | 586 | 781 | 100 | $2,110 |
| Hydrochlorothiazide Generic | 511 | 688 | 105 | $1,043 |
| Atorvastatin Calcium Generic | 498 | 670 | 99 | $2,680 |
| Hydralazine Hcl Generic | 491 | 572 | 84 | $3,464 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 425 | 546 | 90 | $2,425 |
| Entresto Sacubitril/Valsartan | 370 | 382 | 64 | $230K |
| Edarbyclor Azilsartan Med/Chlorthalidone | 335 | 408 | 60 | $94K |
| Amiodarone Hcl Generic | 307 | 351 | 48 | $11K |
Brand drugs: 5,851 claims; generic drugs: 13,579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mikhail Kapchits $1,768 ($1,768 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novartis Pharmaceuticals Corporation with $371.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 24 | $371 |
| E.R. Squibb & Sons, L.L.C. BMY | 17 | $194 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $144 |
| GlaxoSmithKline, LLC. GSK | 5 | $119 |
| Amgen Inc. AMGN | 6 | $116 |
| Pfizer Inc. PFE | 6 | $112 |
| Merck Sharp & Dohme LLC MRK | 5 | $102 |
| Heartflow, Inc. HTFL | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80.52 |
| Scpharmaceuticals Inc. SCPH | 3 | $64.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.